NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nucleo Research

Nucleo Research

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://nucleoresearch.com/

Last Round

Seed

Nov 1, 2025

Est. Valuation

$1.79M

Total Funding Raised

$8.5M

Company Overview

Nucleo Research is a healthcare technology company that develops an AI-powered platform to help oncologists and radiologists extract insights from CT scans to support tumor characterization and treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

medical imaging aioncology airadiology aiagentic aict scan analysisclinical workflow automationtumor lesion sizingbody composition analysissarcopenia detectionRECIST classificationmedtechclinical decision supportai diagnosticshealthcare saasclinical trial imaging

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nucleo Research Comparables

Compare Nucleo Research with similar companies based on industry and business-model similarity.

Nucleo Research comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CoreSlicer
82%
AuctionIQ
79%
Raidium
79%

Nucleo Research Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2025
AcceleratorSep 1, 2025

Key People

Founding team and executive leadership

Luca Pegolotti

Co-founder & CTO

Founding Team

Angelica Iacovelli

CEO, Co-founder

Founding Team

Nucleo Research Investors

Notable investors and investment history

Nucleo Research investors
InvestorRounds
Y CombinatorSeed, Accelerator
Milhouse VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2025

    $500K round led by Y Combinator.

Nucleo Research Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nucleo Research Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nucleo Research's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range2
Year Founded2024
Last FundingNov 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.